Partnering with MaxCyte®
At MaxCyte, we recognize that it takes so much more than innovative technology to bring a new therapy to market—it takes a multifaceted, experienced and adaptable team who know how to direct scientific and product innovation into novel medicines. This is why we form partnerships instead of simply selling an instrument.
With our deep cell engineering and broad regulatory expertise backing your therapeutic breakthroughs, we can improve patients’ lives faster together.
Our Partnerships
Allogene
therapeutics
Beam
therapeutics
Caribou
Biosciences
Catamaran
BIO
CRISPR
therapeutics
CELULARITY
CURAMYS
EDITAS
MEDICINE
INVIOS
INNOVATIVE IMMUNO-ONCOLOGY
INTIMA
BIOSCIENCES
KITE
A GILEAD COMPANY
KSQ
LG CHEM
LYELL
IMMUNOPHARMA
MYELOID
THERAPEUTICS, INC.
NKARTA
therapeutics
PRECISION
BIOSCIENCES
SANA
BIOTECHNOLOGY
VERTEX
VOR
BIOPHARMA
WALKING FISH
THERAPEUTICS
VITTORIA
BIOTHERAPEUTICS
PRIME
MEDICINE
WUGEN
More successful together
By uniting around shared goals, we create synergies that amplify value creation and fuel a faster journey from product and process development through commercialization.
We offer our partners
- Comprehensive technical Support from our globally distributed Field Applications scientific and Field Engineer Teams
- Efficient transition to clinical and commercial cell therapy production through
- Optimized product and process development
- Seamless technology transfer, globally
- On demand and sustained product manufacturing support
- Streamlined product scale-up and/or -out
- Inclusive and flexible global regulatory support
- Robust quality systems
- Continuous operational improvement
- Dedicated global teams for continual and comprehensive product, process and partnership support
Together with our partners, we have enabled clinical trials* across an expanding range of indications
Ready to learn more about partnering with MaxCyte?
Answers are just a click away!